H Hanak

1.0k total citations
24 papers, 816 citations indexed

About

H Hanak is a scholar working on Oncology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, H Hanak has authored 24 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 6 papers in Epidemiology. Recurrent topics in H Hanak's work include HER2/EGFR in Cancer Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). H Hanak is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). H Hanak collaborates with scholars based in Austria, United Kingdom and Japan. H Hanak's co-authors include Peter Böck, D. Scevola, F. Meunier, P. Martino, Shiro Naoe, William P. Duguid, Masahiko Okudaira, G. Mall, Gerald P. Bodey and M Hotchi and has published in prestigious journals such as Annals of Surgery, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

H Hanak

24 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H Hanak Austria	9	344	303	288	154	119	24	816
Maryann L. Huie United States	21	190 0.6×	222 0.7×	99 0.3×	339 2.2×	229 1.9×	34	1.2k
P Poupart Belgium	10	126 0.4×	351 1.2×	215 0.7×	387 2.5×	93 0.8×	11	1.1k
Leonard P. Merkow United States	16	110 0.3×	117 0.4×	230 0.8×	307 2.0×	138 1.2×	43	1.0k
F Arenzana-Seisdedos France	13	144 0.4×	155 0.5×	211 0.7×	209 1.4×	43 0.4×	17	1.1k
Hideaki Tsuzuki Japan	19	592 1.7×	250 0.8×	296 1.0×	337 2.2×	46 0.4×	40	1.3k
Matias Pardo United States	15	100 0.3×	90 0.3×	167 0.6×	170 1.1×	88 0.7×	31	714
Seiichi Miwa Japan	15	312 0.9×	400 1.3×	239 0.8×	349 2.3×	26 0.2×	34	978
Jeffrey K. Taubenberger United States	11	87 0.3×	205 0.7×	330 1.1×	174 1.1×	31 0.3×	15	883
Isabelle Frémaux France	14	107 0.3×	195 0.6×	163 0.6×	304 2.0×	55 0.5×	21	1.4k
James J. Murtagh United States	16	154 0.4×	162 0.5×	75 0.3×	377 2.4×	61 0.5×	32	801

Countries citing papers authored by H Hanak

Since Specialization

Citations

This map shows the geographic impact of H Hanak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Hanak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Hanak more than expected).

Fields of papers citing papers by H Hanak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Hanak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Hanak. The network helps show where H Hanak may publish in the future.

Co-authorship network of co-authors of H Hanak

This figure shows the co-authorship network connecting the top 25 collaborators of H Hanak. A scholar is included among the top collaborators of H Hanak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Hanak. H Hanak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hanak, H, et al.. (1999). Polytetrafluoroethylene in the surgery of cases with severe limitation of abduction Long-term results. Neuro-Ophthalmology. 22(3). 177–185. 8 indexed citations

Stierer, M., Harald Rosén, Renate Weber, et al.. (1998). Comparison of immunohistochemical and biochemical measurement of steroid receptors in primary breast cancer: Evaluation of discordant findings. Breast Cancer Research and Treatment. 50(2). 125–134. 20 indexed citations

Stierer, M., Harald Rosén, Renate Weber, et al.. (1995). A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer. Breast Cancer Research and Treatment. 36(1). 11–21. 17 indexed citations

Medl, M., P. Sevelda, K. Czerwenka, et al.. (1995). DNA Amplification of HER-2/neu and INT-2 Oncogenes in Epithelial Ovarian Cancer. Gynecologic Oncology. 59(3). 321–326. 35 indexed citations

Czerwenka, K., H Hanak, Sepp Leodolter, et al.. (1993). HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples. European Journal of Cancer. 29(11). 1593–1597. 20 indexed citations

Stierer, M., Harald Rosén, Renate Weber, et al.. (1993). Immunohistochemical and Biochemical Measurement of Estrogen and Progesterone Receptors in Primary Breast Cancer Correlation of Histopathology and Prognostic Factors. Annals of Surgery. 218(1). 13–21. 109 indexed citations

Rosén, Anders, P. Sevelda, Michael Klein, et al.. (1993). First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer. British Journal of Cancer. 67(5). 1122–1125. 25 indexed citations

Heinz, R., Guenther G. Steger, Andreas Chott, et al.. (1992). MACOP-B treatment in patients with Ki-1-positive large-cell anaplastic lymphoma. Journal of Cancer Research and Clinical Oncology. 118(4). 314–317. 2 indexed citations

Bodey, Gerald P., William P. Duguid, H Hanak, et al.. (1992). Fungal infections in cancer patients: An international autopsy survey. European Journal of Clinical Microbiology & Infectious Diseases. 11(2). 99–109. 446 indexed citations

10.

Rosén, Anders, et al.. (1992). Non-ovarian peritoneal papillary serous carcinoma with high CA125 levels. Archives of Gynecology and Obstetrics. 251(4). 199–202. 8 indexed citations

11.

Heinz, R., et al.. (1988). [Lymphomas of the gastrointestinal tract].. PubMed. 59(4). 244–7. 2 indexed citations

12.

Heinz, R., E Neumann, H Hanak, et al.. (1985). CHOP-firstline treatment in NHL with unfavorable prognosis ? Evaluation of therapeutic response and factors influencing prognosis. Annals of Hematology. 50(5). 267–276. 2 indexed citations

13.

Heinz, R., H Hanak, & A Stacher. (1985). Progress in the management of high risk non-Hodgkin's lymphomas. Journal of Molecular Medicine. 63(14). 619–626. 2 indexed citations

14.

Heinz, R. & H Hanak. (1984). Non-hodgkin lymphoma following hodgkin's disease. Annals of Hematology. 49(4). 353–357. 4 indexed citations

15.

Volc‐Platzer, Beatrix, et al.. (1982). [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)].. PubMed. 94(4). 108–14. 2 indexed citations

16.

Klaushofer, K., Kathryn R. Koller, Gerhard Baumgartner, et al.. (1981). [Hyperparathyreoidism and chronic lymphocytic leukemia (author's transl)].. PubMed. 8(1). 14–7. 2 indexed citations

17.

Weiss, William A. & H Hanak. (1977). [Epidemiology of primary carcinoma of the liver in Austria (author's transl)].. PubMed. 7(4). 283–8. 2 indexed citations

18.

Hanak, H & P. Böck. (1971). [Diffusion of intravenously injected peroxidase into the periaxonal space of myelin-free, perineurium-free nerves of the myocardium].. PubMed. 27(5). 168–71. 2 indexed citations

19.

Hanak, H & Peter Böck. (1971). Die Feinstruktur der Muskel-Sehnenverbindung von Skelett- und Herzmuskel. Journal of Ultrastructure Research. 36(1-2). 68–85. 69 indexed citations

20.

Böck, P. & H Hanak. (1971). Die Verteilung exogener Peroxydase im Endoneuralraum. Histochemie. 25(4). 361–371. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact